Publications

Anadasabapathy N.  2012.  Self-Destructive But Self-Controlled. Science Translational Medicine. 4(123)

Anandasabapathy N.  2012.  A Kiss That’s Just a Kiss. Science Translational Medicine.

Anandasabapathy N.  2012.  Jack - Not jill - Went up the hill. Science Translational Medicine. 4(155)

Anandasabapathy N.  2012.  New Kid on the Block. Science Translational Medicine.

Anandasabapathy N.  2011.  Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. Journal of Experimental Medicine. :1695-1705.

Anandasabapathy N.  2012.  Unmasking interferon pathways in autoimmune disease. Science Translational Medicine. 4(157)

Anandasabapathy N.  2012.  Sensing Sun Damage. Science Translational Medicine.

Anandasabapathy N.  2012.  A new way for natural killers to find their "missing-self". Science Translational Medicine . 4(163)

Anandasabapathy N.  2012.  Keeping the Peace: Skin Sentinels Maintain Immune Tolerance. Science Translational Medicine.

Anandasabapathy N, Steinman RM.  2014.  Classical Flt3L-dependent dendritic cells control immunity to protein vaccine. Journal of Experimental Medicine. 221(9):1875-91.

Anandasabapathy N.  2003.   An E3 Ubiquitin Ligase that Inhibits Cytokine Gene Transcription Is Expressed in Anergic CD4+ T Cells. Cell Immunity. :535-547.

Anandasabapathy N.  2012.  A New Way for Natural Killers to Find Their “Missing-Self”. Science Translational Medicine.

Anandasabapathy N.  2012.  Separate But Not Equal: Giving the NOD to Innate Immunity in Leprosy. Science Translational Medicine.

Anandasabapathy N, Burke KE.  2011.   Cellular Immunity of the Skin: Langerhans Cells and Dendritic Cells. Innate Immune System of Skin and Oral Mucosa: Properties and Impact in Pharmaceutics, Cosmetics, and Personal Care Products. :195-214.

Anandasabapathy N.  2012.  Neutrophil Superheroes: Casting NETs to Catch Bacteria. Science Translational Medicine.

Anandasabapathy N.  2015.  Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteer. Bone Marrow Transplantation. 50(7):924-930.

Anandasabapthy N.  2013.  FcγRs muscle up dendritic cell cross-presentation. Science Translational Medicine. 5(167)

Breton G, Nussenzweig MC.  2015.  Circulating precursors of human CD1c+ and CD141+ dendritic cells. Journal of Experimental Medicine. 212(3)

C R, JV S.  2008.  Pretibial epidermolysis bullosa. Dermatology Online Journal. :26.

CJ N, N A.  2016.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance. Human Vaccines and Immunotherapeutics. 12(1):104–116.

D’Agostino PM, Gottfried-Blackmore A, Anandasabapathy N, Bulloch K.  2012.  Brain dendritic cells: biology and pathology. Acta Neuropathology. 124(5):599-614.

D’Agostino PM, A AGottfried-, Anandasabapathy N, Bulloch K.  2012.  Brain dendritic cells: biology and pathology. Acta Neuropathologica. :599-614.

Fassò M.  2000.  T cell receptor (TCR)-mediated repertoire selection and loss of TCR vbeta diversity during the initiation of a CD4(+) T cell response in vivo. Journal of Experimental Medicine. :1712-39.

Goyal G, Dranoff G.  2018.  PPAR-γ contributes to immunity by cancer vaccines that secrete GM-CSF. Cancer Immunology Research.

Grindstaff entK.  1998.  Sec6/8 complex is recruited to cell-cell contacts and specifies transport vesicle delivery to the basal-lateral membrane in epithelial cells. Cell. :731-740.